GRIFOLS | GRF - Ebit

Aktienkurs
9.20
Täglich Wechseln
-0.07 -0.71%
Monatlich
-7.70%
Jährlich
9.99%
Q2 Prognose
8.94




Ebit Veränderung Datum
Alcon AG USD 317M 17M 2025-12
Almirall EUR 30.23M 12.8M 2025-12
Amadeus IT EUR 338.9M 149.7M 2025-12
Amarin USD -2.26M 564K 2025-12
argenx SE USD 371.14M 21.17M 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bayer EUR 1.11B 1.51B 2025-12
Cie Automotive EUR 264.84M 21.12M 2025-12
Demant DKK 2.07B 201M 2025-12
Ence Energia y Celulosa EUR -37.27M 22.77M 2025-12
Essilor EUR 1.38B 626M 2025-12
Ferrovial EUR 542M 111M 2025-12
Fresenius EUR 713M 139M 2025-12
Fresenius Medical Care EUR 663M 213.06M 2025-12
Galapagos EUR 780.56M 822.23M 2025-12
Genmab DKK 260M 199M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
GRIFOLS EUR 352.11M 20.18M 2025-09
Hikma Pharmaceutical USD 348M 31M 2025-12
Inditex EUR 2.05B 317M 2025-12
Merck EUR 474M 738M 2025-12
Novartis USD 4.06B 530M 2025-12
Philips EUR 719M 390M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Smith & Nephew USD 440M 50M 2025-12
UCB EUR 1.29B 571M 2025-12
Viscofan EUR 50.32M 1.64M 2025-12